Introduction: The polymer PEI-MP (polyethyleneiminomethyl phosphonic acid) might be labelled with 99mTc. It was initially synthesized for palliative therapy of bone metastases after convenient radiolabelling, however in biodistribution studies performed with different PEI-MP/radionuclides, was obvious that the bladder wall was a target organ [1-3], demonstrating a certain selectivity to bladder cells, and so, to bladder cancer cells. The aim of this study was to evaluate the efficacy of 99mTc-PEI-MP for diagnosis of bladder carcinoma, evaluating in vitro and in vivo the biokinetics and biodistribution of 99mTc-PEI-M
The goal of this investigation was to examine the possibilities for yttrium-90-labeling of the 2,3-d...
Purpose: The development of a prostate-specific membrane antigen (PSMA)-ligand for labeling with dif...
Thesis (Ph.D. (Pharmacology))--North-West University, Potchefstroom Campus, 2006This thesis covers r...
Introduction: The polymer PEI-MP (polyethyleneiminomethyl phosphonic acid) that might be labeled wit...
Introduction: The polymer PEI-MP (polyethyleneimine, functionalised with methylphosphonate groups) w...
Introduction: The water-soluble polymer PEI-MP (polyethyleneimine, functionalised with methylphospho...
Introduction: The water-soluble polymer PEI-MP (polyethyleneimine, functionalised with methylphospho...
Introduction: The aim of this study was to evaluate in vivo the efficacy of 99mTc-PEI- MP (polyethyl...
Introduction: 188Re is a promising radionuclide for metabolic therapy because of the emission of hig...
Introduction: 188Re is a promising radionuclide for metabolic therapy because of the emission of hi...
Resumo da comunicação apresentado ao XII Congresso Nacional de Medicina Nuclear, 12-14 Novembro 2009...
Objectives: PSMA is a well-recognized target for imaging and therapy of prostate cancer (PCa), as it...
OBJECTIVE: To verify whether native avidin, made radioactive through the binding with technetium-99m...
Contains fulltext : 167159.pdf (publisher's version ) (Open Access)Prostate-specif...
Rhenium-188 dimercaptosuccinic acid complex [188Re(V)DMSA], a potential therapeutic analogue of the ...
The goal of this investigation was to examine the possibilities for yttrium-90-labeling of the 2,3-d...
Purpose: The development of a prostate-specific membrane antigen (PSMA)-ligand for labeling with dif...
Thesis (Ph.D. (Pharmacology))--North-West University, Potchefstroom Campus, 2006This thesis covers r...
Introduction: The polymer PEI-MP (polyethyleneiminomethyl phosphonic acid) that might be labeled wit...
Introduction: The polymer PEI-MP (polyethyleneimine, functionalised with methylphosphonate groups) w...
Introduction: The water-soluble polymer PEI-MP (polyethyleneimine, functionalised with methylphospho...
Introduction: The water-soluble polymer PEI-MP (polyethyleneimine, functionalised with methylphospho...
Introduction: The aim of this study was to evaluate in vivo the efficacy of 99mTc-PEI- MP (polyethyl...
Introduction: 188Re is a promising radionuclide for metabolic therapy because of the emission of hig...
Introduction: 188Re is a promising radionuclide for metabolic therapy because of the emission of hi...
Resumo da comunicação apresentado ao XII Congresso Nacional de Medicina Nuclear, 12-14 Novembro 2009...
Objectives: PSMA is a well-recognized target for imaging and therapy of prostate cancer (PCa), as it...
OBJECTIVE: To verify whether native avidin, made radioactive through the binding with technetium-99m...
Contains fulltext : 167159.pdf (publisher's version ) (Open Access)Prostate-specif...
Rhenium-188 dimercaptosuccinic acid complex [188Re(V)DMSA], a potential therapeutic analogue of the ...
The goal of this investigation was to examine the possibilities for yttrium-90-labeling of the 2,3-d...
Purpose: The development of a prostate-specific membrane antigen (PSMA)-ligand for labeling with dif...
Thesis (Ph.D. (Pharmacology))--North-West University, Potchefstroom Campus, 2006This thesis covers r...
Add to ORKG